Your browser doesn't support javascript.
loading
Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung.
Sun, Fangdi; Grenert, James P; Tan, Lisa; Van Ziffle, Jessica; Joseph, Nancy M; Mulvey, Claire K; Bergsland, Emily.
Afiliación
  • Sun F; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Grenert JP; Department of Pathology, University of California, San Francisco, San Francisco, CA.
  • Tan L; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Van Ziffle J; Department of Pathology, University of California, San Francisco, San Francisco, CA.
  • Joseph NM; Department of Pathology, University of California, San Francisco, San Francisco, CA.
  • Mulvey CK; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Bergsland E; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
JCO Precis Oncol ; 6: e2200009, 2022 06.
Article en En | MEDLINE | ID: mdl-35737914
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tumor Carcinoide / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tumor Carcinoide / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Canadá